CPH 0.00% 0.9¢ creso pharma limited

There's always a turning point, page-30

  1. 46 Posts.
    lightbulb Created with Sketch. 17
    Well I've basically put all my notes on here anyway but as far as the company's finances go, I've run off the quaterly numbers & totalled in very basic flatline expectations based on those numbers, then added in the sum totals of major announcements.. minus a well overestimated cost of those earnings.

    Worst case scenario is that they fall short on the quarter, but by a surprisingly close amount. Which I still think would obviously shock the market. Best case scenario is that they've already broken even for the quarter, plus any possible pending deals to be announced. If this happens, it'd be pretty hard for anyone to argue against their real value then.

    Either way, I see very few downsides from this point.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.